Your Question Addresses the Wrong Application of Omnipaque
The evidence provided discusses iohexol (Omnipaque) dosing for GFR measurement via plasma clearance testing and oral/rectal contrast for bowel imaging, not intravenous contrast for CT evaluation of bowel injury. For CT imaging to evaluate large bowel injury, you need standard IV contrast protocols, not the specialized doses described in these kidney function studies.
Standard IV Contrast Dosing for Abdominal CT (Trauma/Bowel Injury Evaluation)
For CT evaluation of suspected large bowel injury, use 100-150 mL of iohexol 300 mg iodine/mL (Omnipaque 300) administered intravenously at 2-3 mL/sec, with imaging in the portal venous phase (60-70 seconds post-injection). 1
Key Dosing Parameters:
- Volume: 100-150 mL of contrast
- Concentration: Omnipaque 300 (300 mg iodine/mL) is standard
- Rate: 2-3 mL/sec injection rate
- Timing: Portal venous phase imaging (60-70 seconds after injection start)
The research evidence demonstrates that 150 mL of iohexol 300 provides optimal enhancement for abdominal CT, producing hepatic enhancement >50 HU for over 60 seconds and the highest percentage of optimum qualitative enhancement 1, 2. A study specifically evaluating polytrauma patients found that 150 mL provided significantly better enhancement than 120 mL (OR 12.05,95% CI 3.50-41.52), with no additional diagnostic benefit from increasing to 180 mL 1.
Clinical Context for Bowel Injury:
When evaluating for large bowel injury on CT, you're looking for:
- Free intraperitoneal air (expected in penetrating trauma)
- Bowel wall thickening or discontinuity
- Mesenteric stranding or hematoma
- Free fluid (most common finding)
- Contrast extravasation (high specificity)
CT has 88% sensitivity and 72% specificity for detecting bowel injury in penetrating trauma 3. The sensitivity is 88% for gunshot wounds and 80% for stab wounds 3.
Important Caveats:
Do not confuse this with oral contrast protocols: The FDA label describes oral administration of diluted Omnipaque (4-9 mg iodine/mL for adults, 9-29 mg iodine/mL for pediatrics) in conjunction with IV contrast for abdominal CT 4. This is a separate consideration and not routinely necessary for bowel injury evaluation.
Avoid the kidney function testing doses: The 5 mL dose of Omnipaque 300 (3235 mg iohexol total) described extensively in your evidence is specifically for plasma clearance GFR measurement [5-5], not diagnostic CT imaging.
Pediatric Dosing:
For pediatric patients, use 2 mL/kg body weight (maximum 100 mL) of iohexol 300 mg iodine/mL 6.